Pharmaceutical

Bavarian Nordic gains US contract for additional mpox vaccine

Bavarian Nordic has received a $63m US contract to produce bulk product and final freeze-dried doses of the JYNNEOS smallpox/mpox vaccine.

Sep 26, 2024 - 04:00
Bavarian Nordic gains US contract for additional mpox vaccine
Bavarian Nordic has received a $63m US contract to produce bulk product and final freeze-dried doses of the JYNNEOS smallpox/mpox vaccine.
Read the original article

Tags:

Previous Article

Biotechnology Equipment Manufacturers, Companies and Suppliers for the Pharmaceu...

Next Article

Generate:Biomedicines and Novartis link on protein therapeutics development

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Regenerative medicine: new focus on VEGF target?

Regenerative medicine: new focus on VEGF target?

Mar 27, 2023

‘I don’t see this as an end to the pandemic’: Ashish Jha on the end of Covid public health emergency

‘I don’t see this as an end to the pandemic’: Ashish Jh...

May 11, 2023

STAT+: Neurocrine reports second late-stage trial success for congenital adrenal hyperplasia drug

STAT+: Neurocrine reports second late-stage trial succe...

Oct 6, 2023